Literature DB >> 2554042

A tumor-associated antigen in the scirrhous gastric carcinoma cell line MK-01 defined by monoclonal antibody S202.

T Yokota1, T Masuko, T Yamaguchi, K Kitamura, T Takahashi, Y Hashimoto.   

Abstract

A monoclonal antibody (MAb) S202, with an IgG1 isotype, that reacted strongly with the scirrhous gastric carcinoma cell line MK-01 was established. MAb S202 reacted with the colonic cancer cell line, SW1116, and the pancreatic cancer cell line, PK-1, when tested by indirect immunofluorescence. The S202 reactive antigen was expressed in the majority of acetone-fixed fresh frozen cancer tissues. Eighty to 100 per cent of the paraffin-embedded sections of stomach, colon and pancreatic adenocarcinoma were positive for the S202 antigen, with diffuse cytoplasmic staining, whereas esophageal and breast cancers demonstrated markedly less immunostaining. Supplemented serum-free medium collected from 7 day old tumor cell cultures were assayed for the presence of antibody-defined antigens. Antigens detected by MAb S202 were released by the cell lines SW1116 and PK-1. The binding of MAb S202 to the colonic adenocarcinoma sections was reduced after treatment with sodium periodate which suggests that respective antigenic determinants are of carbohydrate nature without sialic acid residues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554042     DOI: 10.1007/BF02471627

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  17 in total

1.  Carbohydrate antigen defined by a monoclonal antibody raised against a gastric cancer xenograft.

Authors:  M Watanabe; S Hirohashi; Y Shimosato; Y Ino; T Yamada; S Teshima; T Sekine; O Abe
Journal:  Jpn J Cancer Res       Date:  1985-01

2.  Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.

Authors:  N Ohuchi; J F Simpson; D Colcher; J Schlom
Journal:  Int J Cancer       Date:  1987-12-15       Impact factor: 7.396

3.  Immunohistochemical distribution of the antigenic determinants detected by monoclonal antibodies to carcinoembryonic antigen.

Authors:  A Yachi; K Imai; H Fujita; Y Moriya; M Tanda; T Endo; M Tsujisaki; M Kawaharada
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

4.  Characterization of gastrointestinal tumor-associated carcinoembryonic antigen-related antigens defined by monoclonal antibodies.

Authors:  M Blaszczyk; K Y Pak; M Herlyn; J Lindgren; S Pessano; Z Steplewski; H Koprowski
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

5.  Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Authors:  K Fukushima; M Hirota; P I Terasaki; A Wakisaka; H Togashi; D Chia; N Suyama; Y Fukushi; E Nudelman; S Hakomori
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

6.  A monoclonal antibody reactive with gastric carcinoma.

Authors:  T Sekine; S Hirohashi; H Kitaoka; T Hirota; T Sugimura
Journal:  Gan       Date:  1984-02

7.  Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma.

Authors:  M Herlyn; H F Sears; Z Steplewski; H Koprowski
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.

Authors:  S Lyubsky; J Madariaga; M Lozowski; Y Mishriki; A Schuss; S Chao; J Lundy
Journal:  Am J Clin Pathol       Date:  1988-02       Impact factor: 2.493

9.  Gastrointestinal cancer-associated antigen in immunoperoxidase assay.

Authors:  B F Atkinson; C S Ernst; M Herlyn; Z Steplewski; H F Sears; H Koprowski
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

10.  Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.

Authors:  C Haglund; J Lindgren; P J Roberts; S Nordling
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.